U.S. Atherectomy Devices Market to Double by 2033, Surpassing $627 Million on Back of Cardiovascular Disease Surge

Introduction: A Market on the Rise

The United States is experiencing a sharp rise in cardiovascular disease, with millions of Americans affected by peripheral artery disease (PAD) and coronary artery conditions. Against this backdrop, atherectomy devices—designed to remove arterial plaque and restore blood flow—are becoming essential tools for minimally invasive treatment.

According to Renub Research recent market forecasts, the U.S. atherectomy devices market will expand from US$ 316.05 million in 2024 to US$ 627.59 million by 2033, reflecting a healthy CAGR of 7.92%. This growth underscores the mounting need for advanced interventional solutions that improve patient outcomes while reducing recovery times.

👉 Want to explore detailed market trends, segment insights, and forecasts? 🔗 Request Free Sample Report

Understanding Atherectomy Devices

Atherectomy devices are specialized medical tools used to excise, vaporize, or grind arterial plaque that narrows or blocks blood flow. They are commonly used in percutaneous coronary interventions (PCI) and peripheral artery interventions (PAI).

• Different types of atherectomy devices cater to varying clinical needs:
• Directional atherectomy targets plaque with precision.
• Rotational atherectomy employs a high-speed burr to break through blockages.
• Laser atherectomy vaporizes plaque using focused light energy.
• Orbital atherectomy sands away deposits through a rotating crown.

These devices are often paired with angioplasty and stenting, making them integral to modern cardiovascular treatment strategies.

Growth Drivers in the U.S. Market

Rising Incidence of PAD and Cardiovascular Disease

The CDC estimates that over 12 million Americans live with PAD, many undiagnosed until late in disease progression. Contributing factors such as an aging population, obesity, sedentary lifestyles, and diabetes are amplifying the cardiovascular burden. Atherectomy devices, with their ability to clear severe blockages, are increasingly viewed as frontline tools for treatment.

Technological Innovations

Breakthroughs in device technology are propelling adoption across hospitals and specialty clinics. Advances include:

• Integration of real-time imaging to enhance procedural precision.
• Laser and orbital systems designed to minimize complications.
• Portable, user-friendly devices that improve access in outpatient settings.

In November 2024, Royal Philips announced the first U.S. patient enrollment in its THOR IDE trial, evaluating a combined laser atherectomy and intravascular lithotripsy catheter for PAD treatment—a move signaling growing confidence in hybrid technologies.

Reimbursement and Coverage Expansion

Favorable reimbursement policies are another driver. Medicare and private insurers increasingly recognize atherectomy as a viable, necessary procedure. Expanded coverage reduces patient cost burdens and encourages hospitals to adopt advanced systems, especially benefiting older patients who represent a large share of PAD cases.

Key Challenges Hindering Growth

High Device and Procedure Costs

Despite its clinical value, atherectomy remains expensive. Advanced systems require significant capital investment, and consumable components add recurring costs. For smaller hospitals and clinics, affordability remains a major hurdle, limiting access in certain regions.

Procedural Risks and Skilled Workforce Shortages

Even with modern innovations, atherectomy carries risks such as arterial perforation and restenosis. Successful outcomes depend heavily on highly trained operators. However, the U.S. faces a shortage of interventional cardiologists and vascular surgeons skilled in using advanced atherectomy systems, especially in rural and underserved communities.

👉 For deeper analysis, detailed segment data, and company insights: 🔗 Request Customization Report

Market Segmentation Analysis

By Product Type

• Directional Atherectomy Devices: Gaining popularity for precision plaque removal, especially in eccentric or calcified lesions.
• Laser Atherectomy Devices: Growing fastest, particularly for treating in-stent restenosis and complex lesions.
• Rotational and Orbital Devices: Widely used for severe blockages, with steady adoption in U.S. hospitals.

By Application

• Cardiovascular: Largest segment, driven by the prevalence of coronary artery disease.
• Peripheral Vascular: Expanding rapidly due to rising PAD cases.
• Neurovascular: Smaller but growing niche for specialized applications.

By End User

1. Hospitals dominate the market thanks to advanced infrastructure, reimbursement partnerships, and research collaborations.
2. Ambulatory Care Services are emerging as key growth centers due to shorter recovery times and increasing patient preference for outpatient care.
3. Medical Research Institutes contribute through device trials and innovation partnerships.

Regional and State-Level Insights

California: Innovation Hub

California stands as one of the largest state markets, supported by leading research hospitals, high prevalence of cardiovascular disease, and a favorable insurance environment. The state also attracts medical tourism for advanced procedures.

New York: High Patient Volume

With its dense population and high diabetes prevalence, New York remains a key adoption center. Major hospitals in New York City often act as referral centers for complex cardiovascular cases, supporting innovation adoption.

New Jersey: Expanding Market

Though smaller than California or New York, New Jersey shows strong growth due to an aging population and its proximity to leading medical centers in New York and Philadelphia. Specialty clinics are increasingly adopting advanced devices.

Competitive Landscape

The U.S. market is home to several global medtech leaders actively investing in R&D and product innovation. Key players include:

Boston Scientific Corporation

• Abbott Laboratories
• Medtronic plc
• Cardinal Health
• Terumo Corporation
• Becton, Dickinson and Company
• AngioDynamics Inc.
• Integer Holdings Corporation

These firms focus on expanding product portfolios, conducting clinical trials, and strengthening reimbursement strategies to secure competitive advantage.

Future Outlook

The U.S. atherectomy devices market is poised for strong growth through 2033. With cardiovascular disease remaining the nation’s leading cause of death, demand for minimally invasive procedures will only rise. Key trends expected to shape the market include:

• Integration of AI and imaging technologies to guide real-time procedures.
• Hybrid systems combining atherectomy with lithotripsy or drug delivery.
• Expansion of outpatient and ambulatory care centers as treatment hubs.
• Increased training programs to address the shortage of skilled specialists.

While high costs and procedural risks present barriers, the combination of technology, reimbursement support, and rising disease burden ensures steady growth.

Conclusion

The U.S. atherectomy devices market represents one of the most advanced and dynamic segments in the cardiovascular space. Projected to nearly double in value by 2033, the market is being driven by an aging population, rising cardiovascular disease rates, and accelerating technological breakthroughs.

Hospitals, clinics, and device manufacturers alike are investing in innovation and accessibility to meet patient needs. Despite challenges of cost and workforce shortages, the outlook remains robust: atherectomy devices are set to play a central role in reshaping cardiovascular care in the United States over the coming decade.

Note: If you need details, data, or insights not covered in this report, we are glad to assist. Through our customization service, we will collect and deliver the information you require, tailored to your specific needs. Share your requirements with us, and we will update the report to align with your expectations.